Citadel Advisors’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History
Bought
Maintained
Sold
Other funds holding AFTR
GC
UOC
FTCM
MCM
GCL
RCM
PAMP
Citadel Advisors's AFTR Position: Q2 2022 in Review
Citadel Advisors sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q2 2022, closing a stake of 2,049,614 shares — an estimated $19.8M sold.
Citadel Advisors first reported a position in AFTR in Q4 2021 and held it in 2 quarters. The position peaked at $19.8M in Q1 2022. 47 funds tracked by Wall St. Rank hold AFTR as of Q2 2022.
- Citadel Advisors reported no remaining AfterNext HealthTech Acquisition Corp position as of Q2 2022 after selling out during the quarter.
- Citadel Advisors sold 2,049,614 AfterNext HealthTech Acquisition Corp shares in Q2 2022, an estimated $19.8M.
- Citadel Advisors first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 2 quarters.
- Citadel Advisors's AfterNext HealthTech Acquisition Corp position peaked at $19.8M in Q1 2022.
- 47 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q2 2022.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.